These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 2883609

  • 1. Denervation supersensitivity of striatal D2 dopamine receptors is restricted to the ventro- and dorsolateral regions of the striatum.
    Savasta M, Dubois A, Feuerstein C, Manier M, Scatton B.
    Neurosci Lett; 1987 Feb 24; 74(2):180-6. PubMed ID: 2883609
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Experimental hemiparkinsonism in the rat following chronic unilateral infusion of MPP+ into the nigrostriatal dopamine pathway--II. Differential localization of dopamine and cholecystokinin receptors.
    Beresford IJ, Davenport AP, Sirinathsinghji DJ, Hall MD, Hill RG, Hughes J.
    Neuroscience; 1988 Oct 24; 27(1):129-43. PubMed ID: 3264392
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Regulation of neurotensin-containing neurons in the rat striatum and substantia nigra. Effects of unilateral nigral lesion with 6-hydroxydopamine on neurotensin content and its binding site density.
    Masuo Y, Pélaprat D, Montagne MN, Scherman D, Rostène W.
    Brain Res; 1990 Mar 05; 510(2):203-10. PubMed ID: 1970504
    [Abstract] [Full Text] [Related]

  • 7. Neonatal dopamine lesion in the rat results in enhanced adenylate cyclase activity without altering dopamine receptor binding or dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein (DARPP-32) immunoreactivity.
    Luthman J, Lindqvist E, Young D, Cowburn R.
    Exp Brain Res; 1990 Mar 05; 83(1):85-95. PubMed ID: 1981564
    [Abstract] [Full Text] [Related]

  • 8. Nigrostriatal lesions enhance striatal 3H-apomorphine and 3H-spiroperidol binding.
    Creese I, Snyder SH.
    Eur J Pharmacol; 1979 Jun 15; 56(3):277-81. PubMed ID: 38973
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Substantia nigra 6-hydroxydopamine lesions alter dopaminergic synaptic markers in the nucleus basalis magnocellularis and striatum of rats.
    Geula C, Slevin JT.
    Synapse; 1989 Jun 15; 4(3):248-53. PubMed ID: 2532792
    [Abstract] [Full Text] [Related]

  • 14. [3H]Dihydrotetrabenazine, a new marker for the visualization of dopaminergic denervation in the rat striatum.
    Masuo Y, Pélaprat D, Scherman D, Rostène W.
    Neurosci Lett; 1990 Jun 22; 114(1):45-50. PubMed ID: 1974339
    [Abstract] [Full Text] [Related]

  • 15. Binding of 3H-spiperone and 3H-(-)-sulpiride to dopamine D2 receptors in rat striatal membranes: methodological considerations and demonstration of the identical nature of the binding sites for the two ligands.
    Urwyler S, Coward D.
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Feb 22; 335(2):115-22. PubMed ID: 2951601
    [Abstract] [Full Text] [Related]

  • 16. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR, Duncan GE, Napier TC, Bondy SC, Iorio LC, Mueller RA.
    J Pharmacol Exp Ther; 1987 Jan 22; 240(1):167-76. PubMed ID: 3100767
    [Abstract] [Full Text] [Related]

  • 17. Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. II. No effect on denervation or neuroleptic-induced supersensitivity.
    Staunton DA, Magistretti PJ, Shoemaker WJ, Deyo SN, Bloom FE.
    Brain Res; 1982 Jan 28; 232(2):401-12. PubMed ID: 6322915
    [Abstract] [Full Text] [Related]

  • 18. Dopamine and opiate receptors: localization in the striatum and evidence for their axoplasmic transport in the nigrostriatal and striatonigral pathways.
    Van der Kooy D, Weinreich P, Nagy JI.
    Neuroscience; 1986 Sep 28; 19(1):139-46. PubMed ID: 2431346
    [Abstract] [Full Text] [Related]

  • 19. Chronic eticlopride and dopamine denervation induce equal nonadditive increases in striatal D2 receptor density: autoradiographic evidence against the dual mechanism hypothesis.
    LaHoste GJ, Marshall JF.
    Neuroscience; 1991 Sep 28; 41(2-3):473-81. PubMed ID: 1678501
    [Abstract] [Full Text] [Related]

  • 20. DA uptake sites, D1 and D2 receptors, D2 and preproenkephalin mRNAs and Fos immunoreactivity in rat striatal subregions after partial dopaminergic degeneration.
    Chritin M, Blanchard V, Raisman-Vozari R, Feuerstein C, Agid Y, Javoy-Agid F, Savasta M.
    Eur J Neurosci; 1996 Dec 28; 8(12):2511-20. PubMed ID: 8996800
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.